tiprankstipranks
Trending News
More News >
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
US Market
Advertisement

Soleno Therapeutics (SLNO) Ratios

Compare
803 Followers

Soleno Therapeutics Ratios

SLNO's free cash flow for Q2 2025 was $0.98. For the 2025 fiscal year, SLNO's free cash flow was decreased by $ and operating cash flow was $-0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
15.13 14.89 2.14 2.80 5.83
Quick Ratio
15.01 14.89 2.14 2.80 5.83
Cash Ratio
3.65 14.75 2.00 2.66 5.71
Solvency Ratio
-1.94 -1.60 -1.12 -1.54 -0.68
Operating Cash Flow Ratio
-4.02 -2.17 -2.84 -3.47 -2.93
Short-Term Operating Cash Flow Coverage
0.00 0.00 -134.07 -98.48 0.00
Net Current Asset Value
$ 224.62M$ 148.17M$ -502.00K$ 4.66M$ 30.81M
Leverage Ratios
Debt-to-Assets Ratio
0.16 <0.01 <0.01 0.01 <0.01
Debt-to-Equity Ratio
0.22 <0.01 0.01 0.03 <0.01
Debt-to-Capital Ratio
0.18 <0.01 0.01 0.03 <0.01
Long-Term Debt-to-Capital Ratio
0.17 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.38 1.15 2.56 2.00 1.43
Debt Service Coverage Ratio
-726.91 0.00 -116.83 -97.00 0.00
Interest Coverage Ratio
-778.85 0.00 0.00 0.00 0.00
Debt to Market Cap
0.01 0.00 <0.01 <0.01 0.00
Interest Debt Per Share
1.05 0.02 0.02 0.09 0.03
Net Debt to EBITDA
0.13 4.57 0.66 0.73 1.64
Profitability Margins
Gross Profit Margin
97.87%0.00%0.00%0.00%0.00%
EBIT Margin
-553.73%0.00%0.00%0.00%0.00%
EBITDA Margin
-547.57%0.00%0.00%0.00%0.00%
Operating Profit Margin
-586.69%0.00%0.00%0.00%0.00%
Pretax Profit Margin
-554.49%0.00%0.00%0.00%0.00%
Net Profit Margin
-554.49%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
-554.49%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%84.43%95.64%62.40%
EBT Per EBIT
94.51%94.21%98.65%98.04%67.90%
Return on Assets (ROA)
-54.49%-21.58%-76.68%-83.15%-23.66%
Return on Equity (ROE)
-73.74%-24.75%-196.36%-166.14%-33.76%
Return on Capital Employed (ROCE)
-61.53%-24.46%-127.17%-114.46%-64.38%
Return on Invested Capital (ROIC)
-61.40%-24.42%-105.66%-107.26%-40.08%
Return on Tangible Assets
-55.47%-22.68%-128.57%-129.00%-30.51%
Earnings Yield
-4.42%-5.87%-24.44%-18.08%-2.54%
Efficiency Ratios
Receivables Turnover
1.33 0.00 0.00 0.00 0.00
Payables Turnover
0.11 0.62 1.24 0.68 0.63
Inventory Turnover
0.30 0.00 0.00 0.00 0.00
Fixed Asset Turnover
12.56 0.00 0.00 0.00 0.00
Asset Turnover
0.10 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
0.11 0.00 0.00 0.00 0.00
Cash Conversion Cycle
-1.75K -587.02 -293.49 -538.16 -580.44
Days of Sales Outstanding
275.22 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
1.24K 0.00 0.00 0.00 0.00
Days of Payables Outstanding
3.26K 587.02 293.49 538.16 580.44
Operating Cycle
1.51K 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-1.67 -1.51 -2.47 -5.22 -6.04
Free Cash Flow Per Share
-1.67 -1.51 -2.48 -5.23 -6.04
CapEx Per Share
<0.01 0.00 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-395.67 0.00 -1.60K -1.26K -3.60K
Capital Expenditure Coverage Ratio
-395.67 0.00 -1.60K -1.26K -3.60K
Operating Cash Flow Coverage Ratio
-1.60 -61.89 -134.07 -60.77 -181.47
Operating Cash Flow to Sales Ratio
-2.58 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-1.96%-3.76%-25.01%-17.00%-4.18%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-22.62 -17.03 -4.09 -5.53 -39.30
Price-to-Sales (P/S) Ratio
132.04 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
17.06 4.21 8.03 9.19 13.27
Price-to-Free Cash Flow (P/FCF) Ratio
-51.04 -26.62 -4.00 -5.88 -23.95
Price-to-Operating Cash Flow Ratio
-48.60 -26.62 -4.00 -5.89 -23.96
Price-to-Earnings Growth (PEG) Ratio
-2.18 6.87 0.07 -0.11 0.51
Price-to-Fair Value
17.06 4.21 8.03 9.19 13.27
Enterprise Value Multiple
-23.98 -13.35 -3.14 -4.97 -18.51
Enterprise Value
4.29B 494.53M 68.68M 142.68M 555.20M
EV to EBITDA
-23.98 -13.35 -3.14 -4.97 -18.51
EV to Sales
131.32 0.00 0.00 0.00 0.00
EV to Free Cash Flow
-50.76 -19.83 -3.30 -5.13 -22.00
EV to Operating Cash Flow
-50.89 -19.83 -3.31 -5.14 -22.01
Tangible Book Value Per Share
4.64 9.02 -0.04 0.97 7.42
Shareholders’ Equity Per Share
4.76 9.55 1.23 3.35 10.91
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.16 0.04 0.38
Revenue Per Share
0.65 0.00 0.00 0.00 0.00
Net Income Per Share
-3.59 -2.36 -2.42 -5.56 -3.68
Tax Burden
1.00 1.00 0.84 0.96 0.62
Interest Burden
1.00 1.00 1.00 0.96 0.77
Research & Development to Revenue
2.27 0.00 0.00 0.00 0.00
SG&A to Revenue
3.54 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
3.39 0.00 0.00 0.00 0.00
Income Quality
0.47 0.64 0.86 0.90 1.02
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis